Not sure if this has previously been posted - apologies if it has.
looks similar to the slides of Provost's Feb/2006 FDA committee presentation, though perhaps updated, though difficult for this layperson to tell.
the two KM survival curves highlighting the differences in survival between patients whose Cumulative CD54 Cell Dose was above & below the median as well as Cumulative CD54 Up-regulation above vs. below the median are a little more legible in these slides than Provost's presentation.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.